NCT04699279 - Protective Effect of Statin Against Negative Cardiovascular Remodeling and Organ Dysfunction After Acute Aortic Syndrome Surgery (PANDA III) | Biotech Hunter

Enrollment

300

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions

Acute Aortic SyndromeAortopathy

Interventions

DRUG

Rosuvastatin 10mg

Rosuvastatin 10mg is taken by oral or nasal feeding every day at ang time.

Trial Locations (5)

RECRUITING

The first affiliated hospital of nanjing medical university, Nanjing

RECRUITING

The First Affiliated Hospital of Guangzhou Medical University, Guangzhou

RECRUITING

Affiliated Hospital of Qingdao University, Qingdao

RECRUITING

West China Hospital of Sichuan University, Chengdu

RECRUITING

Beijing Anzhen Hospital, Beijing